Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Single-blind, Randomized, Parallel, Non Inferiority Study to Separately Investigate the Effect of Standard Platelets Versus Platelets Prepared With Two Commercial Procedures of Pathogen Reduction Technologies (PRT) on Bleeding Incidence and Severity in Thrombocytopenic Recipients

NCT01642563 is registered in ClinicalTrials.gov with Centro Nazionale Sangue as lead sponsor.

NCT NCT01642563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01642563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Single-blind, Randomized, Parallel, Non Inferiority Study to Separately Investigate the Effect of Standard Platelets Versus Platelets Prepared With Two Commercial Procedures of Pathogen Reduction Technologies (PRT) on Bleeding Incidence and Severity in Thrombocytopenic Recipients
Lead sponsor
Centro Nazionale Sangue
Phase
Phase 3
Overall status
Terminated
Start date
October 31, 2010
Completion date
March 31, 2015
Enrollment
456 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, lymphoma